FHIR © HL7.org | Server Home | FHIR Server FHIR Server 3.7.21 | FHIR Version n/a User: [n/a]

14689911000001107: Urispas 200 tablets (Sigma Pharmaceuticals Plc) (product)

SNOMED CT Concept\Pharmaceutical / biologic product\...

\UK product\Actual medicinal product\Urispas 200 tablets (Sigma Pharmaceuticals Plc)
\UK product\Virtual medicinal product\Product containing precisely flavoxate hydrochloride 200 milligram/1 each conventional release oral tablet\Urispas 200 tablets (Sigma Pharmaceuticals Plc)
\UK product\Virtual therapeutic moiety\Flavoxate\Product containing only flavoxate in oral dose form (medicinal product form)\Product containing precisely flavoxate hydrochloride 200 milligram/1 each conventional release oral tablet\Urispas 200 tablets (Sigma Pharmaceuticals Plc)
\UK product\Virtual therapeutic moiety\Flavoxate\Product containing precisely flavoxate hydrochloride 200 milligram/1 each conventional release oral tablet\Urispas 200 tablets (Sigma Pharmaceuticals Plc)
\UK product\Trade family\Urispas\Urispas 200 tablets (Sigma Pharmaceuticals Plc)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Apr 2009. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module

51587601000001119 Urispas 200 tablets (Sigma Pharmaceuticals Plc) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

51587701000001112 Urispas 200 tablets (Sigma Pharmaceuticals Plc) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Urispas 200 tablets (Sigma Pharmaceuticals Plc)	Has NHS dm+d (dictionary of medicines and devices) controlled drug category	Controlled drug category No Controlled Drug Status	true	Inferred relationship	Existential restriction modifier
Urispas 200 tablets (Sigma Pharmaceuticals Plc)	Has NHS dm+d (dictionary of medicines and devices) parallel import indicator	Parallel Import - supplier (qualifier value)	false	Inferred relationship	Existential restriction modifier
Urispas 200 tablets (Sigma Pharmaceuticals Plc)	Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator	NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none	true	Inferred relationship	Existential restriction modifier
Urispas 200 tablets (Sigma Pharmaceuticals Plc)	Has NHS dm+d (dictionary of medicines and devices) parallel import indicator	Parallel import	true	Inferred relationship	Existential restriction modifier
Urispas 200 tablets (Sigma Pharmaceuticals Plc)	Is a	Product containing precisely flavoxate hydrochloride 200 milligram/1 each conventional release oral tablet	true	Inferred relationship	Existential restriction modifier
Urispas 200 tablets (Sigma Pharmaceuticals Plc)	Has active ingredient	Flavoxate hydrochloride	false	Inferred relationship	Existential restriction modifier
Urispas 200 tablets (Sigma Pharmaceuticals Plc)	Has manufactured dose form	Tablet	false	Inferred relationship	Existential restriction modifier
Urispas 200 tablets (Sigma Pharmaceuticals Plc)	Has manufactured dose form	Conventional release oral tablet	true	Inferred relationship	Existential restriction modifier
Urispas 200 tablets (Sigma Pharmaceuticals Plc)	VMP prescribing status (attribute)	VMP valid as a prescribable product	true	Inferred relationship	Existential restriction modifier
Urispas 200 tablets (Sigma Pharmaceuticals Plc)	VMP non-availability indicator	Available	true	Inferred relationship	Existential restriction modifier
Urispas 200 tablets (Sigma Pharmaceuticals Plc)	Has excipient	Excipient not declared	true	Inferred relationship	Existential restriction modifier
Urispas 200 tablets (Sigma Pharmaceuticals Plc)	Is a	Urispas	true	Inferred relationship	Existential restriction modifier
Urispas 200 tablets (Sigma Pharmaceuticals Plc)	Has specific active ingredient	Flavoxate hydrochloride	true	Inferred relationship	Existential restriction modifier
Urispas 200 tablets (Sigma Pharmaceuticals Plc)	Has dispensed dose form	Tablet	true	Inferred relationship	Existential restriction modifier
Urispas 200 tablets (Sigma Pharmaceuticals Plc)	Is a	Actual medicinal product	true	Inferred relationship	Existential restriction modifier

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Urispas 200 tablets (Sigma Pharmaceuticals Plc) 100 tablet	Is pack of	False	Urispas 200 tablets (Sigma Pharmaceuticals Plc)	Inferred relationship	Existential restriction modifier
Urispas 200 tablets (Sigma Pharmaceuticals Plc) 100 tablet	Has AMP	True	Urispas 200 tablets (Sigma Pharmaceuticals Plc)	Inferred relationship	Existential restriction modifier
Urispas 200 tablets (Sigma Pharmaceuticals Plc) 90 tablet	Has AMP	True	Urispas 200 tablets (Sigma Pharmaceuticals Plc)	Inferred relationship	Existential restriction modifier

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
51587601000001119	Urispas 200 tablets (Sigma Pharmaceuticals Plc) (product)	en	Fully specified name	Active	Entire term case sensitive	SNOMED CT United Kingdom drug extension module
51587701000001112	Urispas 200 tablets (Sigma Pharmaceuticals Plc)	en	Synonym	Active	Entire term case sensitive	SNOMED CT United Kingdom drug extension module